CLINICAL OUTCOMES WITH FIRST-LINE BEVACIZUMAB AND CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER AND A HISTORY OF DIABETES: RESULTS FROM THE ARIES OBSERVATIONAL COHORT STUDY

被引：1
|
作者：
Bendell, J. [1 ]
Cohn, A. [2 ]
Mun, Y. [3 ]
Fish, S. [3 ]
Sommer, N. [3 ]
Grothey, A. [4 ]
机构：
[1] Sarah Cannon Res Inst, Nashville, TN USA
[2] Rocky Mt Canc Ctr, Denver, CO USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN USA
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu164.10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD - 0010
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study
    Kozloff, Mark F.
    Berlin, Jordan
    Flynn, Patrick J.
    Kabbinavar, Fairooz
    Ashby, Mark
    Dong, Wei
    Sing, Amy P.
    Grothey, Axel
    ONCOLOGY, 2010, 78 (5-6) : 329 - 339
  • [2] Effectiveness of First-Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA
    Franchi, Matteo
    Barni, Sandro
    Tagliabue, Giovanna
    Ricci, Paolo
    Mazzucco, Walter
    Tumino, Rosario
    Caputo, Antonietta
    Corrao, Giovanni
    Corrao, Giovanni
    Franchi, Matteo
    Barni, Sandro
    Tagliabue, Giovanna
    Fabiano, Sabrina
    Barigelletti, Giulio
    Ricci, Paolo
    Gatti, Lucina
    Mazzucco, Walter
    Cusimano, Rosanna
    Vitale, Francesco
    Tumino, Rosario
    Giurdanella, Maria Concetta
    Rollo, Patrizia Concetta
    Spata, Eugenia
    Caputo, Antonietta
    De Ceglie, Maria Carolina
    ONCOLOGIST, 2019, 24 (03): : 358 - 365
  • [3] FIRST-LINE TREATMENT WITH BEVACIZUMAB PLUS CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER: RESULTS FROM A LARGE GERMAN COMMUNITY-BASED OBSERVATIONAL COHORT STUDY
    Arnold, D.
    Kindler, M.
    Petersen, V
    Tummes, D.
    Molle, M.
    Schoberl, C.
    Srock, S.
    Kutscheidt, A.
    Grothe, W.
    ANNALS OF ONCOLOGY, 2010, 21 : 21 - 21
  • [4] Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large community-based observational cohort study in Germany
    Arnold, D.
    Kindler, M.
    Petersen, V.
    Tummes, D.
    Moelle, M.
    Schoeberl, C.
    Srock, S.
    Hinke, A.
    Grothe, W.
    ONKOLOGIE, 2010, 33 : 61 - 61
  • [5] CLINICAL OUTCOMES IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: RESULTS FROM ARIES OBSERVATIONAL COHORT STUDY AND CONFIRMATION OF BRITE DATA ON BEVACIZUMAB BEYOND PROGRESSION
    Cohn, A.
    Bekaii-Saab, T.
    Bendell, J.
    Hurwitz, H.
    Kozloff, M.
    Roach, N.
    Tezcan, H.
    Feng, S.
    Sing, A.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 11 - 11
  • [6] Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX-Bevacizumab or FOLFIRI-Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study
    Bendell, Johanna C.
    Beikaii-Saab, Tanios S.
    Cohn, Allen L.
    Hurwitz, Herbert I.
    Kozloff, Mark
    Tezcan, Haluk
    Roach, Nancy
    Mun, Yong
    Fish, Susan
    Flick, E. Dawn
    Dalal, Darshan
    Grothey, Axel
    ONCOLOGIST, 2012, 17 (12): : 1486 - 1495
  • [7] BEVACIZUMAB PLUS CHEMOTHERAPY IN 2ND LINE METASTATIC COLORECTAL CANCER (MCRC): INITIAL RESULTS FROM ARIES, A SECOND BEVACIZUMAB OBSERVATIONAL COHORT STUDY (OCS)
    Bekaii-Saab, T.
    Bendell, J.
    Cohn, A.
    Hurwitz, H.
    Kozloff, M.
    Roach, N.
    Tezcan, H.
    Feng, S.
    Sing, A.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 20 - 20
  • [8] Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results
    Ralf Hofheinz
    Volker Petersen
    Manfred Kindler
    Mathias Schulze
    Joerg Seraphin
    Heinz-Gert Hoeffkes
    Anette-R Valdix
    Jan Schroeder
    Julia Herrenberger
    Alexander Stein
    Axel Hinke
    Dirk Arnold
    BMC Cancer, 14
  • [9] Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results
    Hofheinz, Ralf
    Petersen, Volker
    Kindler, Manfred
    Schulze, Mathias
    Seraphin, Joerg
    Hoeffkes, Heinz-Gert
    Valdix, Anette-R
    Schroeder, Jan
    Herrenberger, Julia
    Stein, Alexander
    Hinke, Axel
    Arnold, Dirk
    BMC CANCER, 2014, 14
  • [10] ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK
    Khakoo, Shelize
    Chau, Ian
    Pedley, Ian
    Ellis, Richard
    Steward, Will
    Harrison, Mark
    Baijal, Shobhit
    Tahir, Saad
    Ross, Paul
    Raouf, Sherif
    Ograbek, Agnes
    Cunningham, David
    CLINICAL COLORECTAL CANCER, 2019, 18 (04) : 280 - +
12345